EX-99.1 2 imax-ex99_1.htm EX-99.1 EX-99.1

 

Exhibit 99.1

img199560746_0.jpg 

 

 

IMAX CORPORATION REPORTS Q4 AND FULL-YEAR 2023 RESULTS

 

Global entertainment technology platform delivers over 25% YoY growth in FY23 across Revenue, Net Income, Adjusted EBITDA(1) and Adjusted EPS(1)(2)
Full-Year GAAP EPS of $0.46, up from a loss of ($0.40) in FY22; Full-Year Adjusted EPS of $0.94, up from $0.06 in FY22
Net Income of $25 million in FY23 increased from a loss of $(23) million in 2022 while Adjusted EBITDA(2) increases to $128 million in FY23, up 52% from $84 million in FY22
System sales activity increases 174% YoY to 129 signings worldwide in FY23
Company delivers on high end of guidance with 128 system installations in FY23, up from 92 in FY22
IMAX achieves global box office of approximately $1.1 billion, approaching previous record
Full-Year cash from operations more than triples to $59 million in FY23, up from $17 million FY22

 

 

NEW YORK, NY — February 27, 2024 — IMAX Corporation (NYSE: IMAX) today reported financial results for the Fourth Quarter and Full-Year 2023, highlighted by strong top and bottom-line growth for the full-year.

 

“IMAX delivered excellent results in 2023 — we grew Net Income by $48 million, Adjusted EPS by 88 cents, Adjusted EBITDA by 52%, and system installations by nearly 40% — on the strength of demand for our technology, our unique premium model, and a clear preference among consumers worldwide for awe-inspiring IMAX experiences,” said Rich Gelfond, CEO of IMAX.

 

“As the entertainment landscape transforms, it is clear that IMAX is among its premier, in-demand destinations. We drove significant expansion and diversification of our global footprint, with a record 61 of our system installations coming from strategic Rest of World markets such as Japan, South Korea and Europe. Even as we deliver an outsized share of the global box office, we estimate the current IMAX network is only at 47% penetration — with the opportunity to open nearly 2,000 additional locations worldwide.”

 

“Our strong network growth is a direct result of our global content strategy, which has yielded the biggest and most diverse portfolio of IMAX Experiences ever. 2023 saw IMAX deliver a record at the North American box office, highest grossing year ever for local language films and overall box office approaching our best year ever. We are strategically managing our content portfolio to drive greater share of Hollywood releases, grow local language, accelerate our pipeline of IMAX Documentaries, and push further into emerging verticals including music and gaming, live experiences and recurring programming.”

 

“Through our global technology platform, IMAX powers awe-inspiring experiences for audiences around the world — capitalizing on the limitlessness of human imagination and need for shared experiences. We look forward to further capturing this opportunity, growing our network and content portfolio, to deliver results for our shareholders.”

 

_______________

(1)
Non-GAAP Financial Measure. See the discussion at the end of this earnings release for a description of the non-GAAP financial measures used herein, as well as reconciliations to the most comparable GAAP amounts.
(2)
Attributable to common shareholders.

1


 

Fourth Quarter and December Full-Year Financial Highlights

 

 

Three Months Ended

 

 

Year Ended

 

 

December 31,

 

 

December 31,

In millions of U.S. Dollars, except per share data

 

2023

 

 

2022

 

 

YoY %
Change

 

 

2023

 

 

2022

 

 

YoY %
Change

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Revenue

 

$

86.0

 

 

$

98.0

 

 

(12%)

 

 

$

374.8

 

 

$

300.8

 

 

25%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Margin

 

$

43.7

 

 

$

48.8

 

 

(11%)

 

 

$

214.3

 

 

$

156.4

 

 

37%

Gross Margin (%)

 

 

51

%

 

 

50

%

 

 

 

 

 

57

%

 

 

52

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA - attributable to common shareholders(1)(3)

 

$

23.0

 

 

$

27.8

 

 

(17%)

 

 

$

128.2

 

 

$

84.5

 

 

52%

Adjusted EBITDA Margin (%) - attributable to common shareholders(1)(3)

 

 

28

%

 

 

31

%

 

(8%)

 

 

 

37

%

 

 

30

%

 

22%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Adjusted EBITDA(1)(3)(4)

 

$

25.2

 

 

$

31.5

 

 

(20%)

 

 

$

144.0

 

 

$

95.7

 

 

51%

Total Adjusted EBITDA Margin (%)(1)(3)(4)

 

 

29

%

 

 

32

%

 

(9%)

 

 

 

38

%

 

 

32

%

 

21%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income (Loss)(2)

 

$

2.5

 

 

$

2.6

 

 

(3%)

 

 

$

25.3

 

 

$

(22.8

)

 

N/A

Net Income (Loss) per share(2) - basic and diluted

 

$

0.05

 

 

$

0.05

 

 

 

 

 

$

0.46

 

 

$

(0.40

)

 

N/A

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted Net Income(1)(2)

 

$

9.3

 

 

$

10.6

 

 

(12%)

 

 

$

52.1

 

 

$

3.2

 

 

N/A

Adjusted Earnings Per Share(1)(2)

 

$

0.17

 

 

$

0.19

 

 

(11%)

 

 

$

0.94

 

 

$

0.06

 

 

N/A

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding (in millions)(5):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

54.0

 

 

 

54.8

 

 

(2%)

 

 

 

54.3

 

 

 

56.7

 

 

(4%)

Diluted

 

 

55.0

 

 

 

55.7

 

 

(1%)

 

 

 

55.1

 

 

 

57.4

 

 

(4%)

_______________

(1)
Non-GAAP Financial Measure. See the discussion at the end of this earnings release for a description of the non-GAAP financial measures used herein, as well as reconciliations to the most comparable GAAP amounts.
(2)
Attributable to common shareholders.
(3)
Per Credit Facility.
(4)
Total Adjusted EBITDA is equivalent to Total Adjusted EBITDA Attributable to Non-controlling Interests and Common Shareholders.
(5)
Reflects weighted average shares outstanding used in Adjusted Earnings Per Share calculation.

 

 

 

 

 

 

 

2


 

 

Fourth Quarter and Full Year Segment Results(1)

 

 

Content Solutions

 

 

Technology Products and Services

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

 

Gross Margin

 

 

Gross
Margin %

 

 

Revenue

 

 

Gross Margin

 

 

Gross
Margin %

 

4Q23

 

$

19.1

 

 

$

9.7

 

 

 

51

%

 

$

62.5

 

 

 

$

29.9

 

 

 

48

%

4Q22

 

 

29.3

 

 

 

12.1

 

 

 

41

%

 

 

66.1

 

 

 

 

35.2

 

 

 

53

%

% change

 

 

(35

%)

 

 

(20

%)

 

 

 

 

 

(5

%)

 

 

 

(15

%)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FY23

 

$

126.7

 

 

$

74.1

 

 

 

58

%

 

$

234.3

 

 

 

$

129.9

 

 

 

55

%

FY22

 

 

101.8

 

 

 

51.2

 

 

 

50

%

 

 

192.4

 

 

 

 

101.1

 

 

 

53

%

% change

 

 

24

%

 

 

45

%

 

 

 

 

 

22

%

 

 

 

28

%

 

 

 

_______________

(1)
Please refer to the Company’s Form 10-K for the year ended December 31, 2023 for additional segment information.

 

Content Solutions Segment

Content Solutions revenue of $126.7 million increased 24% year-over-year for the full year 2023 while Q4 revenue of $19.1 million decreased 35% year-over-year. Gross box office from IMAX locations for full year 2023 of approximately $1.1 billion was up 25% while Q4 2023 of $170 million was down 32% year-over-year. IMAX set numerous records for box office during 2023 including:
o
Highest full year local language box office of $227 million
o
Highest full year domestic box office of $393 million
o
Highest Q3 box office of $347 million
Gross margin for Content Solutions of $74.1 million for the full year 2023 increased 45% year-over-year while Q4 gross margin of $9.7 million decreased 20% year-over-year. The Company saw significant margin expansion for the full year 2023 (up 800 basis points) and Q4 2023 (up 1000 basis points) driven by the operating leverage in our business along with our disciplined cost management.

 

Technology Products and Services Segment

Technology Products and Services revenues and gross margin for full year 2023 increased 22% year-over-year to $234.3 million and 28% year-over-year to $129.9 million, respectively. Q4 revenue and gross margin decreased 5% year-over-year to $62.5 million and 15% year-over-year to $29.9 million, respectively.
For the full year 2023 the Company installed 128 systems compared to 92 systems in full year 2022. Of those, 75 systems were under sales and hybrid JRSA arrangements, compared to 46 systems in the prior year.
During the fourth quarter the Company installed 69 systems compared to 52 systems in the fourth quarter of 2022. Of those, 38 systems were under sales and hybrid JRSA arrangements, compared to 24 systems in the prior year.
Commercial network growth accelerated with the number of IMAX locations increasing 4% year-over-year to 1,693. The Company ended 2023 with a backlog of 450 IMAX systems.

 

 

 

 

3


 

Operating Cash Flow and Liquidity

Net cash provided by operating activities for full year 2023 was $58.6 million compared to $17.3 million in the prior period with the increase reflecting the higher profits year-over-year and improvements in working capital.

 

As of December 31, 2023, the Company’s available liquidity was $407 million. The Company's liquidity includes cash and cash equivalents of $76 million, $276 million in available borrowing capacity under the Credit Facility, and $55 million in available borrowing capacity under IMAX China’s revolving facilities. Total debt, excluding deferred financing costs, was $257 million as of December 31, 2023.

 

In 2021, the Company issued $230.0 million of 0.500% Convertible Senior Notes due 2026 (“Convertible Notes”). In connection with the pricing of the Convertible Notes, the Company entered into privately negotiated capped call transactions with an initial cap price of $37.2750 per share of the Company's common shares.

 

Share Count and Capital Return

The weighted average basic and diluted shares outstanding used in the calculation of adjusted EPS for the full year of 2023 were 54.3 million and 55.1 million, respectively, compared to 56.7 million and 57.4 million, respectively for the full year 2022, a decrease year-over-year of 4% for both basic and diluted shares outstanding.

 

For the full year 2023, the Company repurchased 1.6 million common shares at an average price of $16.45 per share, for a total of $26.4 million, excluding commission, with $24.2 million of repurchases coming in the fourth quarter of 2023. Subsequent to year-end, the Company repurchased 1.2 million common shares at an average price of $13.99 per share, for a total of $16.2 million, excluding commission, year-to-date through February 26, 2024.

 

On June 14, 2023, the Company announced a 3-year extension to its share-repurchase program through June 30, 2026. The current share-repurchase program authorizes the Company to repurchase up to $400.0 million of its common shares, of which approximately $151.0 million remains available.

 

2024 Guidance

The Company expects the following for the full year 2024:

IMAX Gross Box Office: Similar to 2023
System Installations: 120 to 150 Systems
Total Consolidated Adjusted EBITDA Margin: High 30’s percent

 

Supplemental Materials

For more information about the Company’s results, please refer to the IMAX Investor Relations website located at investors.imax.com.

 

Investor Relations Website and Social Media

On a monthly basis, the Company posts quarter-to-date box office results on the IMAX Investor Relations website located at investors.imax.com. The Company expects to provide such updates within five business days of month-end, although the Company may change this timing without notice.

 

The Company may post additional information on the Company’s corporate and Investor Relations website which may be material to investors. Accordingly, investors, media and others interested in the Company should monitor the Company’s website in addition to the Company’s press releases, SEC filings and public conference calls and webcasts, for additional information about the Company.

 

 

 

4


 

 

Conference Call

The Company will host a conference call today at 4:30 PM ET to discuss its full year and fourth quarter 2023 financial results. This call is being webcast and can be accessed at investors.imax.com. To access the call via telephone, interested parties please pre-register here: https://register.vevent.com/register/BI5eba9aa253da46dfb62bb6d573394a9d and you will be provided with a dial-in number and unique pin. To avoid delays, we encourage participants to dial into the conference call ten minutes ahead of the scheduled start time. A replay of the call will be available via webcast at investors.imax.com.

 

 

5


 

About IMAX Corporation

IMAX, an innovator in entertainment technology, combines proprietary software, architecture, and equipment to create experiences that take you beyond the edge of your seat to a world you've never imagined. Top filmmakers and studios are utilizing IMAX systems to connect with audiences in extraordinary ways, making IMAX's network among the most important and successful theatrical distribution platforms for major event films around the globe.

 

IMAX is headquartered in New York, Toronto, and Los Angeles, with additional offices in London, Dublin, Tokyo, and Shanghai. As of December 31, 2023, there were 1,772 IMAX systems (1,693 commercial multiplexes, 12 commercial destinations, 67 institutional) operating in 90 countries and territories. Shares of IMAX China Holding, Inc., a subsidiary of IMAX Corporation, trade on the Hong Kong Stock Exchange under the stock code “1970”.

 

IMAX®, IMAX® 3D, Experience It In IMAX®, The IMAX Experience®, DMR®, Filmed For IMAX®, IMAX LIVETM, IMAX Enhanced® are trademarks and trade names of IMAX Corporation or its subsidiaries that are registered or otherwise protected under laws of various jurisdictions. For more information, visit www.imax.com. You can also connect with IMAX on Instagram (www.instagram.com/company/imax), Facebook (www.facebook.com/imax), LinkedIn (www.linkedin.com/company/imax), X (www.twitter.com/imax), and YouTube (www.youtube.com/imaxmovies).

 

For additional information please contact:

 

Investors:

IMAX Corporation, New York

Jennifer Horsley

212-821-0154

jhorsley@IMAX.com

Media:

IMAX Corporation, New York

Mark Jafar

212-821-0102

mjafar@imax.com

 

 

 

6


 

Forward-Looking Statements

 

This earnings release contains forward looking statements that are based on IMAX management's assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. These forward-looking statements include, but are not limited to, business and technology strategies and measures to implement strategies, competitive strengths, goals, expansion and growth of business, operations and technology, future capital expenditures (including the amount and nature thereof), industry prospects and consumer behavior, plans and references to the future success of IMAX Corporation together with its consolidated subsidiaries (the “Company”) and expectations regarding the Company's future operating, financial and technological results. These forward-looking statements are based on certain assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors it believes are appropriate in the circumstances. However, whether actual results and developments will conform with the expectations and predictions of the Company is subject to a number of risks and uncertainties, including, but not limited to, risks associated with investments and operations in foreign jurisdictions and any future international expansion, including those related to economic, political and regulatory policies of local governments and laws and policies of the United States and Canada, as well as geopolitical conflicts; risks related to the Company’s growth and operations in China; the performance of IMAX remastered films and other films released to the IMAX network; the signing of IMAX System agreements; conditions, changes and developments in the commercial exhibition industry; risks related to currency fluctuations; the potential impact of increased competition in the markets within which the Company operates, including competitive actions by other companies; the failure to respond to change and advancements in digital technology; risks relating to consolidation among commercial exhibitors and studios; risks related to brand extensions and new business initiatives; conditions in the in-home and out-of-home entertainment industries; the opportunities (or lack thereof) that may be presented to and pursued by the Company; risks related to cyber-security and data privacy; risks related to the Company’s inability to protect the Company’s intellectual property; risks related to climate change; risks related to weather conditions and natural disasters that may disrupt or harm the Company’s business; risks related to the Company’s indebtedness and compliance with its debt agreements; general economic, market or business conditions; risks related to political, economic and social instability; the failure to convert system backlog into revenue; changes in laws or regulations; any statements of belief and any statements of assumptions underlying any of the foregoing; other factors and risks outlined in the Company's periodic filings with the SEC; and other factors, many of which are beyond the control of the Company. Consequently, all of the forward-looking statements made in this earnings release are qualified by these cautionary statements, and actual results or anticipated developments by the Company may not be realized, and even if substantially realized, may not have the expected consequences to, or effects on, the Company. These factors, other risks and uncertainties and financial details are discussed in the Company’s most recent Annual Report on Form 10-K. The Company undertakes no obligation to update publicly or otherwise revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 

7


 

Primary Reporting Groups

 

The Companys Chief Executive Officer (“CEO”) is its Chief Operating Decision Maker (“CODM”), as such term is defined under U.S. GAAP. The CODM, along with other members of management, assesses segment performance based on segment revenues and gross margins. Selling, general and administrative expenses, research and development costs, the amortization of intangible assets, provision for (reversal of) current expected credit losses, certain write-downs, interest income, interest expense, and income tax (expense) benefit are not allocated to the Companys segments.

In the first quarter of 2023, the Company revised its internal segment reporting, including the information provided to the CODM to assess segment performance and allocate resources.

 

The Company has the following reportable segments:

 

(i)
Content Solutions, which principally includes the digital remastering of films and other content into IMAX formats for distribution to the IMAX network. To a lesser extent, the Content Solutions segment also earns revenue from the distribution of large-format documentary films and exclusive experiences ranging from live performances to interactive events with leading artists and creators, as well as film post-production services.

 

(ii)
Technology Products and Services, which includes results from the sale or lease of IMAX Systems, as well as from the maintenance of IMAX Systems. To a lesser extent, the Technology Product and Services segment also earns revenue from certain ancillary theater business activities, including after-market sales of IMAX System parts and 3D glasses.

 

Transactions between segments are valued at exchange value. Inter-segment profits are eliminated upon consolidation, as well as for the disclosures below.

 

 

 

8


 

IMAX Network and Backlog

 

 

 

Three Months
Ended December 31,

 

 

Year
Ended December 31,

 

System Signings(1):

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Sales Arrangements

 

 

10

 

 

 

11

 

 

 

64

 

 

 

21

 

Hybrid JRSA

 

 

 

 

 

 

 

 

 

 

 

3

 

Traditional JRSA

 

 

25

 

 

 

1

 

 

 

65

 

 

 

23

 

   Total IMAX System signings

 

 

35

 

 

 

12

 

 

 

129

 

 

 

47

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months
Ended December 31,

 

 

Year
Ended December 31,

 

System Installations(2):

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Sales Arrangements

 

 

35

 

 

 

21

 

 

 

70

 

 

 

38

 

Hybrid JRSA

 

 

3

 

 

 

3

 

 

 

5

 

 

 

8

 

Traditional JRSA

 

 

31

 

 

 

28

 

 

 

53

 

 

 

46

 

   Total IMAX System installations

 

 

69

 

 

 

52

 

 

 

128

 

 

 

92

 

 

 

 

Year
Ended December 31,

 

 

System Backlog:

 

2023

 

 

 

2022

 

 

Sales Arrangements

 

 

164

 

 

 

 

162

 

 

Hybrid JRSA

 

 

103

 

 

 

 

120

 

 

Traditional JRSA

 

 

183

 

 

 

 

168

 

 

Total System backlog

 

 

450

 

 

 

 

450

 

 

 

 

 

 

 

 

 

 

 

 

 

Year
Ended December 31,

 

 

System Network:

 

2023

 

 

 

2022

 

 

Commercial Multiplex Systems

 

 

 

 

 

 

 

 

Sales Arrangements

 

 

769

 

 

 

 

702

 

 

Hybrid JRSA

 

 

138

 

 

 

 

151

 

 

Traditional JRSA

 

 

786

 

 

 

 

780

 

 

Total Commercial Multiplex Systems

 

 

1,693

 

 

 

 

1,633

 

 

Commercial Destination Systems

 

 

12

 

 

 

 

12

 

 

Institutional Systems

 

 

67

 

 

 

 

71

 

 

Total System network

 

 

1,772

 

 

 

 

1,716

 

 

______________

(1) System signings include new signings of 32 in Q4 2023, 9 in Q4 2022, 108 in the full year 2023 and 30 in the full year 2022.

 

(2) System installations include new systems installations of 47 in Q4 2023, 21 in Q4 2022, 86 in the full year 2023 and 56 in the full year 2022.

9


 

 

IMAX CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands of U.S. dollars, except per share amounts)

 

 

 

 

Three Months Ended

 

 

 

 

 

 

 

 

 

 

December 31,

 

 

Year Ended

 

 

 

 

(Unaudited)

 

 

December 31,

 

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Revenues

 

 

 

 

 

 

 

 

 

 

 

 

Technology sales

 

$

35,337

 

 

$

33,888

 

 

$

100,792

 

 

$

69,158

 

Image enhancement and maintenance services

 

 

35,508

 

 

 

44,094

 

 

 

189,752

 

 

 

161,379

 

Technology rentals

 

 

12,954

 

 

 

18,060

 

 

 

75,566

 

 

 

61,786

 

Finance income

 

 

2,219

 

 

 

2,004

 

 

 

8,729

 

 

 

8,482

 

 

 

 

 

86,018

 

 

 

98,046

 

 

 

374,839

 

 

 

300,805

 

Costs and expenses applicable to revenues

 

 

 

 

 

 

 

 

 

 

 

 

Technology sales

 

 

17,805

 

 

 

17,346

 

 

 

46,756

 

 

 

37,610

 

Image enhancement and maintenance services

 

 

18,586

 

 

 

25,575

 

 

 

88,056

 

 

 

81,834

 

Technology rentals

 

 

5,939

 

 

 

6,278

 

 

 

25,686

 

 

 

25,006

 

 

 

 

42,330

 

 

 

49,199

 

 

 

160,498

 

 

 

144,450

 

Gross margin

 

 

43,688

 

 

 

48,847

 

 

 

214,341

 

 

 

156,355

 

Selling, general and administrative expenses

 

 

35,070

 

 

 

37,862

 

 

 

144,406

 

 

 

138,043

 

Research and development

 

 

2,722

 

 

 

1,633

 

 

 

10,110

 

 

 

5,300

 

Amortization of intangible assets

 

 

1,250

 

 

 

1,417

 

 

 

4,578

 

 

 

4,829

 

Credit loss expense (reversal), net

 

 

170

 

 

 

398

 

 

 

1,759

 

 

 

8,547

 

Asset impairments

 

 

144

 

 

 

 

 

 

144

 

 

 

4,470

 

Restructuring and executive transition costs

 

 

1,593

 

 

 

 

 

 

2,946

 

 

 

 

Income (loss) from operations

 

 

2,739

 

 

 

7,537

 

 

 

50,398

 

 

 

(4,834

)

Realized and unrealized investment gains (losses)

 

 

29

 

 

 

(29

)

 

 

465

 

 

 

70

 

Retirement benefits non-service expense

 

 

(179

)

 

 

(139

)

 

 

(411

)

 

 

(556

)

Interest income

 

 

648

 

 

 

252

 

 

 

2,486

 

 

 

1,428

 

Interest expense

 

 

(1,776

)

 

 

(1,523

)

 

 

(6,821

)

 

 

(5,877

)

Income (loss) before taxes

 

 

1,461

 

 

 

6,098

 

 

 

46,117

 

 

 

(9,769

)

Income tax recovery (expense)

 

 

1,850

 

 

 

(2,017

)

 

 

(13,051

)

 

 

(10,108

)

Net income (loss)

 

 

3,311

 

 

 

4,081

 

 

 

33,066

 

 

 

(19,877

)

Net income attributable to non-controlling interests

 

 

(771

)

 

 

(1,468

)

 

 

(7,731

)

 

 

(2,923

)

Net income (loss) attributable to common shareholders

 

$

2,540

 

 

$

2,613

 

 

$

25,335

 

 

$

(22,800

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share attributable to common shareholders

 

Basic

 

$

0.05

 

 

$

0.05

 

 

$

0.47

 

 

$

(0.40

)

Diluted

 

$

0.05

 

 

$

0.05

 

 

$

0.46

 

 

$

(0.40

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding (in thousands):

 

Basic

 

 

53,973

 

 

 

54,816

 

 

 

54,310

 

 

 

56,674

 

Diluted

 

 

54,983

 

 

 

55,659

 

 

 

55,146

 

 

 

56,674

 

Additional Disclosure:

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

$

13,545

 

 

$

13,998

 

 

$

60,022

 

 

$

56,661

 

Amortization of deferred financing costs

 

$

493

 

 

$

712

 

 

$

2,235

 

 

$

3,177

 

 

10


 

IMAX CORPORATION

CONSOLIDATED BALANCE SHEETS

(In thousands of dollars, except share amounts)

 

 

 

As of December 31,

 

 

 

2023

 

 

2022

 

Assets

 

 

 

 

 

 

Cash and cash equivalents

 

$

76,200

 

 

$

97,401

 

Accounts receivable, net of allowance for credit losses

 

 

136,259

 

 

 

136,142

 

Financing receivables, net of allowance for credit losses

 

 

127,154

 

 

 

129,384

 

Variable consideration receivable, net of allowance for credit losses

 

 

64,338

 

 

 

44,024

 

Inventories

 

 

31,584

 

 

 

31,534

 

Prepaid expenses

 

 

12,345

 

 

 

12,343

 

Film assets, net of accumulated amortization

 

 

6,786

 

 

 

5,277

 

Property, plant and equipment, net of accumulated depreciation

 

 

243,299

 

 

 

252,896

 

Investment in equity securities

 

 

 

 

 

1,035

 

Other assets

 

 

20,879

 

 

 

15,665

 

Deferred income tax assets, net of valuation allowance

 

 

7,988

 

 

 

9,900

 

Goodwill

 

 

52,815

 

 

 

52,815

 

Other intangible assets, net of accumulated amortization

 

 

35,022

 

 

 

32,738

 

Total assets

 

$

814,669

 

 

$

821,154

 

Liabilities

 

 

 

 

 

 

Accounts payable

 

$

26,386

 

 

$

25,237

 

Accrued and other liabilities

 

 

111,013

 

 

 

117,286

 

Deferred revenue

 

 

67,105

 

 

 

70,940

 

Revolving credit facility borrowings, net of unamortized debt issuance costs

 

 

22,924

 

 

 

36,111

 

Convertible notes and other borrowings, net of unamortized discounts and debt issuance costs

 

229,131

 

 

 

226,912

 

Deferred income tax liabilities

 

 

12,521

 

 

 

14,900

 

Total liabilities

 

 

469,080

 

 

 

491,386

 

Commitments, contingencies and guarantees

 

 

 

 

 

 

Non-controlling interests

 

 

658

 

 

 

722

 

Shareholders' equity

 

 

 

 

 

 

Capital stock common shares — no par value. Authorized — unlimited number.

 

 

 

 

 

 

53,260,276 issued and outstanding (December 31, 2022 — 54,148,614 issued and outstanding)

 

 

389,048

 

 

 

376,715

 

Other equity

 

 

185,087

 

 

 

185,678

 

Statutory surplus reserve

 

 

3,932

 

 

 

3,932

 

Accumulated deficit

 

 

(292,845

)

 

 

(293,124

)

Accumulated other comprehensive loss

 

 

(12,081

)

 

 

(9,846

)

Total shareholders' equity attributable to common shareholders

 

 

273,141

 

 

 

263,355

 

Non-controlling interests

 

 

71,790

 

 

 

65,691

 

Total shareholders' equity

 

 

344,931

 

 

 

329,046

 

Total liabilities and shareholders' equity

 

$

814,669

 

 

$

821,154

 

 

 

11


 

IMAX CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands of dollars)

 

 

 

Years Ended December 31,

 

 

 

2023

 

 

2022

 

Operating Activities

 

 

 

 

 

 

 

 

Net income (loss)

 

$

 

33,066

 

 

$

 

(19,877

)

Adjustments to reconcile net income (loss) to cash provided by operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

 

60,022

 

 

 

 

56,661

 

Amortization of deferred financing costs

 

 

 

2,235

 

 

 

 

3,177

 

Credit loss expense, net

 

 

 

1,759

 

 

 

 

8,547

 

Write-downs, including asset impairments

 

 

 

1,884

 

 

 

 

7,176

 

Deferred income tax benefit

 

 

 

(1,447

)

 

 

 

(2,073

)

Share-based and other non-cash compensation

 

 

 

24,230

 

 

 

 

27,573

 

Unrealized foreign currency exchange (gain) loss

 

 

 

(212

)

 

 

 

1,108

 

Realized and unrealized investment gain

 

 

 

(465

)

 

 

 

(70

)

Changes in assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

 

(1,907

)

 

 

 

(29,003

)

Inventories

 

 

 

(285

)

 

 

 

(5,529

)

Film assets

 

 

 

(20,394

)

 

 

 

(19,598

)

Deferred revenue

 

 

 

(3,882

)

 

 

 

(11,572

)

Changes in other operating assets and liabilities

 

 

 

(35,989

)

 

 

 

801

 

Net cash provided by operating activities

 

 

 

58,615

 

 

 

 

17,321

 

Investing Activities

 

 

 

 

 

 

 

 

Purchase of property, plant and equipment

 

 

 

(6,491

)

 

 

 

(8,424

)

Investment in equipment for joint revenue sharing arrangements

 

 

 

(18,000

)

 

 

 

(19,803

)

Interest in film classified as a financial instrument

 

 

 

 

 

 

 

(4,731

)

Acquisition of other intangible assets

 

 

 

(8,344

)

 

 

 

(4,394

)

Proceeds from sale of equity securities

 

 

 

1,045

 

 

 

 

 

Acquisition of SSIMWAVE Inc., net of cash and cash equivalents acquired

 

 

 

 

 

 

 

(15,939

)

Net cash used in investing activities

 

 

 

(31,790

)

 

 

 

(53,291

)

Financing Activities

 

 

 

 

 

 

 

 

Proceeds from revolving credit facility borrowings

 

 

 

39,717

 

 

 

 

37,871

 

Repayments of revolving credit facility borrowings

 

 

 

(53,248

)

 

 

 

(3,600

)

Proceeds from other borrowings

 

 

 

322

 

 

 

 

 

Repayment of other borrowings

 

 

 

(53

)

 

 

 

 

Credit facility amendment fees paid

 

 

 

(46

)

 

 

 

(2,279

)

Repurchase of common shares, IMAX Corporation

 

 

 

(26,823

)

 

 

 

(80,124

)

Repurchase of common shares, IMAX China

 

 

 

(15

)

 

 

 

(3,043

)

Taxes withheld and paid on employee stock awards vested

 

 

 

(6,466

)

 

 

 

(3,687

)

Principal payment under finance lease obligations

 

 

 

(480

)

 

 

 

(948

)

Dividends paid to non-controlling interests

 

 

 

(1,438

)

 

 

 

(2,704

)

Net cash used in financing activities

 

 

 

(48,530

)

 

 

 

(58,514

)

Effects of exchange rate changes on cash

 

 

 

504

 

 

 

 

2,174

 

Decrease in cash and cash equivalents during year

 

 

 

(21,201

)

 

 

 

(92,310

)

Cash and cash equivalents, beginning of year

 

 

 

97,401

 

 

 

 

189,711

 

Cash and cash equivalents, end of year

 

$

 

76,200

 

 

$

 

97,401

 

 

 

 

 

 

 

 

12


 

Segment Revenue and Gross Margin

 

(In thousands of dollars)

 

Three Months Ended

 

 

Years Ended

 

 

 

December 31,

 

 

December 31,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Revenue

 

 

 

 

 

 

 

 

 

 

 

 

Content Solutions

 

 

19,093

 

 

 

29,320

 

 

 

126,698

 

 

 

101,820

 

Technology Products and Services

 

 

62,490

 

 

 

66,107

 

 

 

234,303

 

 

 

192,368

 

Sub-total for reportable segments

 

 

81,583

 

 

 

95,427

 

 

 

361,001

 

 

 

294,188

 

All Other(1)

 

 

4,435

 

 

 

2,619

 

 

 

13,838

 

 

 

6,617

 

Total

 

$

86,018

 

 

$

98,046

 

 

$

374,839

 

 

$

300,805

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross Margin

 

 

 

 

 

 

 

 

 

 

 

 

Content Solutions

 

 

9,709

 

 

 

12,122

 

 

 

74,106

 

 

 

51,240

 

Technology Products and Services

 

 

29,880

 

 

 

35,179

 

 

 

129,946

 

 

 

101,055

 

Sub-total for reportable segments

 

 

39,589

 

 

 

47,301

 

 

 

204,052

 

 

 

152,295

 

All Other(1)

 

 

4,099

 

 

 

1,546

 

 

 

10,289

 

 

 

4,060

 

Total

 

$

43,688

 

 

$

48,847

 

 

$

214,341

 

 

$

156,355

 

______________

(1)
All Other includes the results from Streaming and Consumer Technology and other ancillary activities.

 

 

 

 

 

 

 

 

 

13


 

IMAX CORPORATION

NON-GAAP FINANCIAL MEASURES

(in thousands of U.S. dollars)

In this release, the Company presents adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per basic and diluted share, EBITDA, Adjusted EBITDA per Credit Facility, Adjusted EBITDA margin as supplemental measures of the Company’s performance, which are not recognized under U.S. GAAP. Adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per basic and diluted share exclude, where applicable: (i) share-based compensation; (ii) COVID-19 government relief benefits, net; (iii) realized and unrealized investment gains or losses; (iv) transaction-related expenses; and (v) restructuring and executive transition costs, as well as the related tax impact of these adjustments.

The Company believes that these non-GAAP financial measures are important supplemental measures that allow management and users of the Company’s financial statements to view operating trends and analyze controllable operating performance on a comparable basis between periods without the after-tax impact of share-based compensation and certain unusual items included in net income (loss) attributable to common shareholders. Although share-based compensation is an important aspect of the Company’s employee and executive compensation packages, it is a non-cash expense and is excluded from certain internal business performance measures.

A reconciliation from net income (loss) attributable to common shareholders and the associated per share amounts to adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share is presented in the table below. Net income (loss) attributable to common shareholders and the associated per share amounts are the most directly comparable GAAP measures because they reflect the earnings relevant to the Company’s shareholders, rather than the earnings attributable to non-controlling interests.

In addition to the non-GAAP financial measures discussed above, management also uses “EBITDA,” as such term is defined in the Company’s Credit Agreement, and which is referred to herein as “Adjusted EBITDA per Credit Facility.” As allowed by the Credit Agreement, Adjusted EBITDA per Credit Facility includes adjustments in addition to the exclusion of interest, taxes, depreciation and amortization. Adjusted EBITDA per Credit Facility measure is presented to allow a more comprehensive analysis of the Company’s operating performance and to provide additional information with respect to the Company’s compliance against its Credit Agreement requirements when applicable. In addition, the Company believes that Adjusted EBITDA per Credit Facility presents relevant and useful information widely used by analysts, investors and other interested parties in the Company’s industry to evaluate, assess and benchmark the Company’s results.

EBITDA is defined as net income or loss excluding (i) income tax expense or benefit; (ii) interest expense, net of interest income; (iii) depreciation and amortization, including film asset amortization; and (iv) amortization of deferred financing costs. Adjusted EBITDA per Credit Facility is defined as EBITDA excluding: (i) share-based and other non-cash compensation; (ii) realized and unrealized investment gains or losses; (iii) transaction-related expenses; (iv) restructuring and executive transition costs; and (v) write-downs, net of recoveries, including asset impairments and credit loss expense.

A reconciliation of net income (loss) attributable to common shareholders, which is the most directly comparable GAAP measure, to EBITDA and Adjusted EBITDA per Credit Facility is presented in the table below. Net income (loss) attributable to common shareholders is the most directly comparable GAAP measure because it reflects the earnings relevant to the Company’s shareholders, rather than the earnings attributable to non-controlling interests.

In this release, the Company also presents free cash flow, which is not recognized under U.S. GAAP, as a supplemental measure of the Company’s liquidity. The Company definition of free cash flow deducts only normal recurring capital expenditures, including the Company’s investment in joint revenue sharing arrangements, the purchase of property, plant and equipment and the acquisition of other intangible assets (from the Consolidated Statements of Cash Flows), from net cash provided by or used in operating activities. Management believes that free cash flow is a supplemental measure of the cash flow available to reduce debt, add to cash balances, and fund other financing activities. Free cash flow does not represent residual cash flow available for discretionary expenditures. A reconciliation of cash provided by operating activities to free cash flow is presented below.

These non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Additionally, the non-GAAP financial measures used by the Company should not be considered as a substitute for, or superior to, the comparable GAAP amounts.

 

14


 

Adjusted EBITDA per Credit Facility

 

 

For the Three Months Ended December 31, 2023 (1)

 

 

For the Three Months Ended December 31, 2022 (1)

 

 

 

Attributable to
Non-controlling

 

 

Less:

 

 

 

 

 

Attributable to
Non-controlling

 

 

Less:

 

 

 

 

 

 

Interests and

 

 

Attributable to

 

 

Attributable to

 

 

Interests and

 

 

Attributable to

 

 

Attributable to

 

 

 

Common

 

 

Non-controlling

 

 

Common

 

 

Common

 

 

Non-controlling

 

 

Common

 

 

 

Shareholders

 

 

Interests

 

 

Shareholders

 

 

Shareholders

 

 

Interests

 

 

Shareholders

 

(In thousands of U.S. Dollars)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reported net income

 

$

 

3,311

 

 

$

 

771

 

 

$

 

2,540

 

 

$

 

4,081

 

 

$

 

1,468

 

 

$

 

2,613

 

Add (subtract):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income tax expense

 

 

 

(1,850

)

 

 

 

(147

)

 

 

 

(1,703

)

 

 

 

2,016

 

 

 

 

786

 

 

 

 

1,230

 

Interest expense, net of interest income

 

 

 

636

 

 

 

 

(137

)

 

 

 

773

 

 

 

 

559

 

 

 

 

(15

)

 

 

 

574

 

Depreciation and amortization, including film asset amortization

 

 

 

13,545

 

 

 

 

1,161

 

 

 

 

12,384

 

 

 

 

13,998

 

 

 

 

1,109

 

 

 

 

12,889

 

Amortization of deferred financing costs(2)

 

 

 

493

 

 

 

 

 

 

 

 

493

 

 

 

 

712

 

 

 

 

 

 

 

 

712

 

EBITDA

 

$

 

16,135

 

 

$

 

1,648

 

 

$

 

14,487

 

 

$

 

21,366

 

 

$

 

3,348

 

 

$

 

18,018

 

Stock and other non-cash compensation

 

 

 

6,400

 

 

 

 

144

 

 

 

 

6,256

 

 

 

 

8,063

 

 

 

 

205

 

 

 

 

7,858

 

Unrealized investment (gains) losses

 

 

 

(29

)

 

 

 

 

 

 

 

(29

)

 

 

 

29

 

 

 

 

 

 

 

 

29

 

Transaction-related expenses(3)

 

 

 

327

 

 

 

 

208

 

 

 

 

119

 

 

 

 

166

 

 

 

 

 

 

 

 

166

 

Write-downs, including asset impairments and credit loss expense

 

 

 

812

 

 

 

 

(37

)

 

 

 

849

 

 

 

 

1,867

 

 

 

 

162

 

 

 

 

1,705

 

Restructuring and executive transition costs(4)

 

 

 

1,593

 

 

 

 

258

 

 

 

 

1,335

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA per Credit Facility

 

$

 

25,238

 

 

$

 

2,221

 

 

$

 

23,017

 

 

$

 

31,491

 

 

$

 

3,715

 

 

$

 

27,776

 

Revenues attributable to common shareholders(5)

 

 

 

86,018

 

 

 

 

4,687

 

 

 

 

81,331

 

 

 

 

98,046

 

 

 

 

7,273

 

 

 

 

90,773

 

Adjusted EBITDA margin attributable to common shareholders

 

 

 

29.3

%

 

 

 

47.4

%

 

 

 

28.3

%

 

 

 

32.1

%

 

 

 

51.1

%

 

 

 

30.6

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the Twelve Months Ended December 31, 2023 (1)

 

 

For the Twelve Months Ended December 31, 2022 (1)

 

 

 

Attributable to
Non-controlling

 

 

Less:

 

 

 

 

 

Attributable to
Non-controlling

 

 

Less:

 

 

 

 

 

 

Interests and

 

 

Attributable to

 

 

Attributable to

 

 

Interests and

 

 

Attributable to

 

 

Attributable to

 

 

 

Common

 

 

Non-controlling

 

 

Common

 

 

Common

 

 

Non-controlling

 

 

Common

 

 

 

Shareholders

 

 

Interests

 

 

Shareholders

 

 

Shareholders

 

 

Interests

 

 

Shareholders

 

(In thousands of U.S. Dollars)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reported net income (loss)

 

$

 

33,066

 

 

$

 

7,731

 

 

$

 

25,335

 

 

$

 

(19,877

)

 

$

 

2,923

 

 

$

 

(22,800

)

Add (subtract):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income tax expense

 

 

 

13,051

 

 

 

 

1,725

 

 

 

 

11,326

 

 

 

 

10,108

 

 

 

 

1,256

 

 

 

 

8,852

 

Interest expense, net of interest income

 

 

 

2,101

 

 

 

 

(408

)

 

 

 

2,509

 

 

 

 

1,272

 

 

 

 

(251

)

 

 

 

1,523

 

Depreciation and amortization, including film asset
   amortization

 

 

 

60,022

 

 

 

 

5,312

 

 

 

 

54,710

 

 

 

 

56,661

 

 

 

 

4,820

 

 

 

 

51,841

 

Amortization of deferred financing costs(2)

 

 

 

2,235

 

 

 

 

 

 

 

 

2,235

 

 

 

 

3,177

 

 

 

 

 

 

 

 

3,177

 

EBITDA

 

$

 

110,475

 

 

$

 

14,360

 

 

$

 

96,115

 

 

$

 

51,341

 

 

$

 

8,748

 

 

$

 

42,593

 

Stock and other non-cash compensation

 

 

 

24,230

 

 

 

 

774

 

 

 

 

23,456

 

 

 

 

27,573

 

 

 

 

760

 

 

 

 

26,813

 

Unrealized investment gains

 

 

 

(465

)

 

 

 

(93

)

 

 

 

(372

)

 

 

 

(70

)

 

 

 

 

 

 

 

(70

)

Transaction-related expenses(3)

 

 

 

3,569

 

 

 

 

208

 

 

 

 

3,361

 

 

 

 

1,122

 

 

 

 

 

 

 

 

1,122

 

Write-downs, including asset impairments and credit loss expense

 

 

 

3,273

 

 

 

 

362

 

 

 

 

2,911

 

 

 

 

15,723

 

 

 

 

1,723

 

 

 

 

14,000

 

Restructuring and executive transition costs(4)

 

 

 

2,946

 

 

 

 

258

 

 

 

 

2,688

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA per Credit Facility

 

$

 

144,028

 

 

$

 

15,869

 

 

$

 

128,159

 

 

$

 

95,689

 

 

$

 

11,231

 

 

$

 

84,458

 

Revenues attributable to common shareholders(5)

 

 

 

374,839

 

 

 

 

25,674

 

 

 

 

349,165

 

 

 

 

300,805

 

 

 

 

20,883

 

 

 

 

279,922

 

Adjusted EBITDA margin attributable to common shareholders

 

 

 

38.4

%

 

 

 

61.8

%

 

 

 

36.7

%

 

 

 

31.8

%

 

 

 

53.8

%

 

 

 

30.2

%

______________

(1)
The Senior Secured Net Leverage Ratio is calculated using Adjusted EBITDA per Credit Facility determined on a trailing twelve-month basis.
(2)
The amortization of deferred financing costs is recorded within Interest Expense in the Condensed Consolidated Statement of Operations.
(3)
Reflects costs incurred resulting from the Company's proposal to acquire the outstanding 96.3 million shares in IMAX China.
(4)
Reflects costs in connection with the departure of the President, IMAX Entertainment and Executive Vice President of the Company and other employees to capture efficiencies and centralize certain operational roles.

 

 

 

 

15


 

(5)

 

(In thousands of U.S. Dollars)

 

Three months ended
December 31, 2023

 

 

Three months ended
December 31, 2022

 

 

Year ended
December 31, 2023

 

 

Year ended
December 31, 2022

 

Total revenues

 

 

 

 

 

$

 

86,018

 

 

 

 

 

 

$

 

98,046

 

 

 

 

 

 

$

 

374,839

 

 

 

 

 

$

 

300,805

 

Greater China revenues

 

$

 

16,521

 

 

 

 

 

 

$

 

25,728

 

 

 

 

 

 

$

 

90,496

 

 

 

 

 

 

$

 

73,330

 

 

 

 

Non-controlling interest ownership percentage(6)

 

 

 

28.37

%

 

 

 

 

 

 

 

28.27

%

 

 

 

 

 

 

 

28.37

%

 

 

 

 

 

 

 

28.48

%

 

 

 

Deduction for non-controlling interest share of revenues

 

 

 

 

 

 

 

(4,687

)

 

 

 

 

 

 

 

(7,273

)

 

 

 

 

 

 

 

(25,674

)

 

 

 

 

 

 

(20,883

)

Revenues attributable to common shareholders

 

 

 

 

 

$

 

81,331

 

 

 

 

 

 

$

 

90,773

 

 

 

 

 

 

$

 

349,165

 

 

 

 

 

$

 

279,922

 

(6) Weighted average ownership percentage for change in non-controlling interest share

 

 

Adjusted Net Income Attributable to Common Shareholders and Adjusted Net Income Per Share

 

 

Three Months Ended

 

 

Three Months Ended

 

 

 

December 31, 2023

 

 

December 31, 2022

 

(In thousands of U.S. dollars, except per share amounts)

 

Net Income

 

 

Per Diluted Share

 

 

Net Income

 

 

Per Diluted Share

 

Net income attributable to common shareholders

 

$

2,540

 

 

$

0.05

 

 

$

2,613

 

 

$

0.05

 

Adjustments(1):

 

 

 

 

 

 

 

 

 

 

 

 

Share-based compensation

 

 

6,074

 

 

 

0.11

 

 

 

7,730

 

 

 

0.14

 

Unrealized investment gains

 

 

(32

)

 

 

 

 

 

29

 

 

 

 

Transaction-related expenses(2)

 

 

119

 

 

 

 

 

 

166

 

 

 

 

Restructuring and executive transition costs(3)

 

 

1,335

 

 

 

0.02

 

 

 

 

 

 

 

Tax impact on items listed above

 

 

(747

)

 

 

(0.01

)

 

 

17

 

 

 

 

Adjusted net income(1)

 

$

9,289

 

 

$

0.17

 

 

$

10,555

 

 

$

0.19

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average basic shares outstanding

 

 

 

 

 

53,973

 

 

 

 

 

 

54,816

 

Weighted average diluted shares outstanding

 

 

 

 

 

54,983

 

 

 

 

 

 

55,659

 

 

 

 

Year Ended

 

 

Year Ended

 

 

 

December 31, 2023

 

 

December 31, 2022

 

(In thousands of U.S. dollars, except per share amounts)

 

Net Income

 

 

Per Diluted Share

 

 

Net (Loss)
Income

 

 

Per Diluted Share

 

Net income (loss) attributable to common shareholders

 

$

25,335

 

 

$

0.46

 

 

$

(22,800

)

 

$

(0.40

)

Adjustments(1):

 

 

 

 

 

 

 

 

 

 

 

 

Share-based compensation

 

 

23,184

 

 

 

0.42

 

 

 

26,382

 

 

 

0.46

 

COVID-19 government relief benefits, net

 

 

 

 

 

 

 

 

(373

)

 

 

(0.01

)

Unrealized investment gains

 

 

(558

)

 

 

(0.01

)

 

 

(70

)

 

 

 

Transaction-related expenses(2)

 

 

3,361

 

 

 

0.06

 

 

 

1,122

 

 

 

0.02

 

Restructuring and executive transition costs(3)

 

 

2,688

 

 

 

0.05

 

 

 

 

 

 

 

Tax impact on items listed above

 

 

(1,931

)

 

 

(0.04

)

 

 

(1,054

)

 

 

(0.02

)

Adjusted net income(1)

 

$

52,079

 

 

$

0.94

 

 

$

3,207

 

 

$

0.06

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Weighted average shares outstanding - basic

 

 

 

 

 

54,310

 

 

 

 

 

 

56,674

 

 Weighted average shares outstanding - diluted

 

 

 

 

 

55,146

 

 

 

 

 

 

57,371

 

_______________

(1)
Reflects amounts attributable to common shareholders.
(2)
Reflects costs in connection with the Company’s proposal to acquire the outstanding 96.3 million shares in IMAX China in 2023 and costs incurred associated with the acquisition of SSIMWAVE in 2022.
(3)
Reflects costs in connection with the departure of the President, IMAX Entertainment and Executive Vice President of the Company and other employees to capture efficiencies and centralize certain operational roles.

 

16


 

Free Cash Flow

 

 

Year Ended

 

 

Year Ended

 

(In thousands of U.S. Dollars)

 

December 31, 2023

 

 

December 31, 2022

 

Net cash provided by operating activities

 

$

 

58,615

 

 

$

 

17,321

 

Purchase of property, plant and equipment

 

 

 

(6,491

)

 

 

 

(8,424

)

Acquisition of other intangible assets

 

 

 

(8,344

)

 

 

 

(4,394

)

Free cash flow before growth CAPEX

 

 

 

43,780

 

 

 

 

4,503

 

Investment in equipment for joint revenue sharing arrangements

 

 

 

(18,000

)

 

 

 

(19,803

)

Free cash flow

 

$

 

25,780

 

 

$

 

(15,300

)

 

17